Hemostatic profile of infants with spontaneous ...
Type de document :
Compte-rendu et recension critique d'ouvrage
Titre :
Hemostatic profile of infants with spontaneous prematurity: can we predict intraventricular hemorrhage development?
Auteur(s) :
Hochart, Audrey [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
NUYTTEN, Alexandra [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
Pierache, Adeline [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
Bauters, Anne [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
RAUCH, ANTOINE [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
Wibaut, Bénédicte [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
Susen, Sophie [Auteur]
Goudemand, Jenny [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
NUYTTEN, Alexandra [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
Pierache, Adeline [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
Bauters, Anne [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
RAUCH, ANTOINE [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
Wibaut, Bénédicte [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
Susen, Sophie [Auteur]
Goudemand, Jenny [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Unité de Biostatistique et de Recherche Clinique [UBRC]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
Titre de la revue :
Italian Journal of Pediatrics
Éditeur :
BioMed Central
Date de publication :
2019-08-28
ISSN :
1720-8424
Mot(s)-clé(s) en anglais :
Prematurity Haemostasis Intraventricular hemorrhage Thrombocytopenia
Prematurity
Haemostasis
Intraventricular hemorrhage
Thrombocytopenia
Prematurity
Haemostasis
Intraventricular hemorrhage
Thrombocytopenia
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Background: Defining hemostatic profile for preterm infants is a challenge when severe bleedings are frequent. Methods: The aim was to define the hemostatic profile at birth of infants with spontaneous prematurity and to ...
Lire la suite >Background: Defining hemostatic profile for preterm infants is a challenge when severe bleedings are frequent. Methods: The aim was to define the hemostatic profile at birth of infants with spontaneous prematurity and to evaluate whether characteristic profiles can predict the development of intraventricular hemorrhage (IVH) in prematures. Results: We included 122 newborns with a median age of 31 5/7 gestational age (GA) [29 2/7 ;34 0/7 ] and median weight of 1145 g [785;1490]. Levels of fibrinogen, factor II (FII) and factor V (FV) rose with GA (p = 0.017,p = 0.009, p = 0.001). In the group of 23 0/7-28 6/7 GA, the 5th percentile was defined as 0.6 g/L for fibrinogen, 15 IU/dL for FII and 16 IU/dL for factor V (n = 30). In the group of 29 0/7-32 6/7 GA, the 5th percentile was defined as 1.0 g/L for fibrinogen, 24 IU/dL for FII and 41 IU/dL for factor V (n = 46). In the group of 33 0/7-36 6/7 GA, the 5th percentile was defined as 1.0 g/L for fibrinogen, 24 IU/dL for FII and 30 IU/dL for factor V (n = 46). Level of fibrinogen was higher in case of vaginal delivery and lower in case of IUGR. Only lower level of FV at birth was significantly associated with IVH (63.5 [46.0; 76.5] vs 74.0 [58.0; 89.0], p = 0.026) with an unadjusted OR per SD increase in FV of 0.57 (95%CI, 0.34 to 0.96). After adjustment for age, the association between FV level and IVH was slightly attenuated (adjusted OR, 0.70; 95%CI, 0.40 to 1.23) but remained not significant (p = 0.22).There was no correlation with FII and fibrinogen. Conclusions: We can define hemostastic profile of prematures and corroborate references ranges for studied parameters. Further large studies are still called for, to correlate the grade of hemorrhage and the factor V level at birth.Lire moins >
Lire la suite >Background: Defining hemostatic profile for preterm infants is a challenge when severe bleedings are frequent. Methods: The aim was to define the hemostatic profile at birth of infants with spontaneous prematurity and to evaluate whether characteristic profiles can predict the development of intraventricular hemorrhage (IVH) in prematures. Results: We included 122 newborns with a median age of 31 5/7 gestational age (GA) [29 2/7 ;34 0/7 ] and median weight of 1145 g [785;1490]. Levels of fibrinogen, factor II (FII) and factor V (FV) rose with GA (p = 0.017,p = 0.009, p = 0.001). In the group of 23 0/7-28 6/7 GA, the 5th percentile was defined as 0.6 g/L for fibrinogen, 15 IU/dL for FII and 16 IU/dL for factor V (n = 30). In the group of 29 0/7-32 6/7 GA, the 5th percentile was defined as 1.0 g/L for fibrinogen, 24 IU/dL for FII and 41 IU/dL for factor V (n = 46). In the group of 33 0/7-36 6/7 GA, the 5th percentile was defined as 1.0 g/L for fibrinogen, 24 IU/dL for FII and 30 IU/dL for factor V (n = 46). Level of fibrinogen was higher in case of vaginal delivery and lower in case of IUGR. Only lower level of FV at birth was significantly associated with IVH (63.5 [46.0; 76.5] vs 74.0 [58.0; 89.0], p = 0.026) with an unadjusted OR per SD increase in FV of 0.57 (95%CI, 0.34 to 0.96). After adjustment for age, the association between FV level and IVH was slightly attenuated (adjusted OR, 0.70; 95%CI, 0.40 to 1.23) but remained not significant (p = 0.22).There was no correlation with FII and fibrinogen. Conclusions: We can define hemostastic profile of prematures and corroborate references ranges for studied parameters. Further large studies are still called for, to correlate the grade of hemorrhage and the factor V level at birth.Lire moins >
Langue :
Anglais
Vulgarisation :
Non
Source :
Fichiers
- document
- Accès libre
- Accéder au document
- 13052_2019_Article_709.pdf
- Accès libre
- Accéder au document